Clinical Trial: A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07827599) titled 'A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants' on Sept. 15.

Brief Summary: The main purpose of the study is to evaluate the efficacy of a single dose of baloxavir marboxil compared with placebo in the PEP of influenza virus infection with respect to symptomatic, laboratory-confirmed influenza in participants who are household contacts (HHCs) of participants with influenza (index participants).

Study Start Date: Sept. 22

Study Type: INTERVENTIONAL

Condition: Influenza, Human Respiratory Tract Infections Post-exposure ...